Cancer Genome Atlas Reveals Similarities Between Certain Breast and Ovarian Cancers
USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening
Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival
Immunotherapy Demonstrates Disease Control in Phase II Study
Finasteride Does Not Affect Quality of Life, Says Study
Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years
Study: Lack of Sleep Linked With Agressive Breast Cancers
HPV Can Affect Response To Radiation Therapies
Researchers Find 16 Gene Variants Linked to Colorectal Cancer Using CRCgene Database
NCI-Approved CTEP Trials For the Month of September
FDA Approves Imaging Agent For Recurrent Prostate Cancer
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”
